The Supreme Court in its order dated April 30 observed that the central government could consider using its powers under Sections 92, 100 or 102 of the Patents Act to increase production of essential drugs to meet demand.Centre says exercise of patent waiver provisions for COVID-19 vaccines,drugs #39;counter-productive#39;, prefers diplomacy
The Supreme Court in its order dated April 30 observed that the central government could consider using its powers under Sections 92, 100 or 102 of the Patents Act to increase production of essential drugs to meet demand.
Subscribe to:
Post Comments (Atom)
-
The company, one of the leading manufacturers of soda ash, had initiated the process of carving out its textiles business into GHCL Textile...
-
The BRLLR linked to RBI Repo Rate is revised downwards in line with the reduction on Reserve Bank of India Repo Rate from 5.15 percent to 4...
-
The company did not export units last month while it had dispatched 804 Etios units in in June 2019.
No comments:
Post a Comment